Comparative expression of matrix-associated genes and inflammatory cytokines-associated genes according to disc degeneration: Analysis of living human nucleus pulposus

Journal of Spinal Disorders and Techniques

Volumn 24, Issue 6, 2011, Pages 352-357

  Park, Jeong Yoon ^a   Kuh, Sung Uk ^a   Park, Hyo Suk ^a   Kim, Keun Su ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

aggrecan; alkaline phosphatase; degenerative disc; IL 1 ; osteocalcin; Sox9; TNF ; type I collagen; type II collagen

Indexed keywords

AGGRECAN; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; INTERLEUKIN 1BETA; MESSENGER RNA; OSTEOCALCIN; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERVERTEBRAL DISK DEGENERATION; NUCLEUS PULPOSUS; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGGRECANS; ALKALINE PHOSPHATASE; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE II; GENE EXPRESSION; HUMANS; INTERLEUKIN-1ALPHA; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOCALCIN; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051786460     PISSN: 15360652     EISSN: 15392465     Source Type: Journal    
DOI: 10.1097/BSD.0b013e3181fee4df     Document Type: Article

References (22)

1. Yoon ST, Patel NM. Molecular therapy of the intervertebral disc. Eur Spine J. 2006;15:379-388.
2. Kuh SU, Zhu Y, Li J, et al. A comparison of three cell types as potential candidates for intervertebral disc therapy: annulus fibrosus cells, chondrocytes, and bone marrow derived cells. Joint Bone Spine. 2009;76:70-74.
3. Evans C. Potential biologic therapies for the intervertebral disc. J Bone Joint Surg Am. 2006;88:95-98.
4. Antoniou J, Goudsouzian NM, Heathfield TF, et al. The human lumbar endplate. Evidence of changes in biosynthesis and denaturation of the extracellular matrix with growth, maturation, aging, and degeneration. Spine. 1996;21:1153-1161. (Pubitemid 26161379)
5. Peng B, Hao J, Hou S, et al. Possible pathogenesis of painful intervertebral disc degeneration. Spine. 2006;31:560-566.
6. Zhao C, Wang L, Jiang L, et al. The cell biology of intervertebral disc aging and degeneration. Ageing Res Rev. 2007;6:247-261. (Pubitemid 47405307)
7. Diefenderfer DL, Brighton CT. Microvascular pericytes express aggrecan message which is regulated by BMP-2. Biochem Biophys Res Commun. 2000;269:172-178. (Pubitemid 30440273)
8. Yoon ST, Kim KS, Li J, et al. The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine. 2003;28: 1773-1780. (Pubitemid 37012751)
9. Fassett DR, Kurd MF, Vaccaro AR. Biologic solutions for degenerative disk disease. J Spinal Disord Tech. 2009;22:297-308.
10. Adam M, Deyl Z. Degenerated annulus fibrosus of the intervertebral disc contains collagen type II. Ann Rheum Dis. 1984;43: 258-263. (Pubitemid 14172574)
11. Lee S, Moon CS, Sul D, et al. Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem. 2009;42: 1504-1511.
12. Millward-Sadler SJ, Costello PW, Freemont AJ, et al. Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration. Arthritis Res. 2009;11:65.
13. Kuh SU, Zhu Y, Li J, et al. Can TGF-beta1 and rhBMP-2 act in synergy to transform bone marrow stem cells to discogenic-type cells? Acta Neurochir (Wien). 2008;150:1073-1079.
14. Pfirrmann CW, Metzdorf A, Zanetti M, et al. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine. 2001;26:1873-1878. (Pubitemid 32844681)
15. Sguin CA, Pilliar RM, Roughley PJ, et al. Tumor necrosis factoralpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine. 2005;30:1940-1948. (Pubitemid 41292217)
16. Rutges JP, Kummer JA, Oner FC, et al. Increased MMP-2 activity during intervertebral disc degeneration is correlated to MMP-14 levels. J Pathol. 2008;214:523-530. (Pubitemid 351340573)
17. Hoyland JA, Le Maitre C, Freemont AJ. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology. 2008;47:809-814. (Pubitemid 351796365)
18. Yoshida T, Park JS, Yokosuka K, et al. Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro. Spine. 2009;34:1544-1548.
19. Weiler C, Nerlich AG, Bachmeier BE, et al. Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine. 2005;30:44-53. (Pubitemid 40209276)
20. Yoon ST, Park JS, Kim KS, et al. ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine. 2004;29:2603-2611. (Pubitemid 40353245)
21. Fei Q, Jiang X, Chen T, et al. Changes with age and the effect of recombinant human BMP-2 on proteoglycan and collagen gene expression in rabbit anulus fibrosus cells. Acta Biochim Biophys Sin (Shanghai). 2006;38:773-779. (Pubitemid 44749582)
22. Sheikh H, Zakharian K, De La Torre RP, et al. In vivo intervertebral disc regeneration using stem cell-derived chondroprogenitors. J Neurosurg Spine. 2009;10:265-272.